APhA and LearnSomething Team Up to Tackle REMS

Published Online: Tuesday, March 29, 2011
Follow Pharmacy_Times:
A new partnership between the American Pharmacists Association (APhA) and heath care continuing education provider LearnSomething aims to simplify how pharmacists comply with the FDA’s educational requirements for Risk Evaluation and Mitigation Strategies (REMS).

Working with LearnSomething, APhA will consolidate REMS information into a comprehensive e-learning platform equipped with both educational and compliance tracking tools. The program is scheduled to launch in the 2nd quarter of 2011 and will include general REMS education and REMS information for specific medications.

The announcement coincided with the organization’s annual meeting, where a diverse group of stakeholders discussed APhA’s ongoing efforts to improve REMS while representing the interests of pharmacy. At the meeting, held March 25-28 in Seattle, Washington, APhA leaders outlined their past achievements in the REMS arena and identified strategies for going forward.

Marcie Bough, PharmD, APhA’s senior director of government affairs, explained at the meeting’s Legislative and Regulatory Update session that APhA “has led pharmacy in REMS discussions…focusing on the need to use a standardized, system-based approach to improve REMS, decrease the burden on the health care system, and ensure patient access to needed medications,” according to an APhA statement.

Through these and other initiatives, the organization that represents more than 60,000 of the nation’s pharmacists hopes to realize its vision for drug-specific patient education: a streamlined suite of medication resources that are consistent, user-friendly, and easily integrated into pharmacy workflow.

Related Articles
Jade Megyeri, University of Colorado Skaggs School of Pharmacy student, shares what drew her to pharmacy school.
From optimizing inhaler technique in patients with chronic obstructive pulmonary disease, to catching red flags when dispensing controlled substances to patients with chronic pain, pharmacists can improve patient outcomes in an evolving treatment landscape.
Daniel Abazia, PharmD, BCPS, clinical assistant professor at Ernest Mario School of Pharmacy, talks about how prescription drug monitoring programs assist pharmacists.
In his keynote address at the American Pharmacists Association’s general session, Daniel Kraft, MD, chairman of the medicine and neuroscience tracks for Singularity University, posited that it is time to think outside the box and reimagine health and pharmacy.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times